This inventor holds 1 USPTO granted patent. Top assignee: Emet Pharmaceuticals, LLC. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Nutan Kumar Gangrade: Innovator in Delayed Release Pharmaceutical Compositions
Introduction
Nutan Kumar Gangrade is a notable inventor based in Hockessin, Delaware, who has made significant contributions to the field of pharmaceuticals. She is recognized for her innovative work in developing a delayed release dosage form that enhances the effectiveness of therapeutic drugs.
Latest Patents
Nutan Kumar Gangrade holds a patent for a delayed release pharmaceutical composition. This invention involves a solid dosage form that includes a core made up of a therapeutically effective amount of a drug, such as mesalamine. The composition features a pH-sensitive coating that consists of a mixture of two different pH-sensitive polymers. The first polymer dissolves in an aqueous solution at a pH of about 7 or greater, while the second polymer dissolves at a pH of about 6 or greater. The weight ratio of these polymers ranges from about 2:1 to about 4:1, and the weight gain from the pH-sensitive coating is between 8% and 15% of the core, including any subcoating.
Career Highlights
Nutan Kumar Gangrade is currently associated with Emet Pharmaceuticals, LLC, where she continues to advance her research and development efforts in the pharmaceutical industry. Her work focuses on creating innovative solutions that improve drug delivery and patient outcomes.
Collaborations
Throughout her career, Nutan has collaborated with esteemed colleagues, including Madurai Gurusamy Ganesan and Ramaswamy Balakrishnan. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Nutan Kumar Gangrade is a pioneering inventor whose work in delayed release pharmaceutical compositions has the potential to significantly impact the field of medicine. Her innovative approach and dedication to improving drug delivery systems highlight her valuable contributions to the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile